TEL AVIV-YAFO, Israel — A hospital in Israel is predicting patients’ risk of suffering pulmonary embolism (PE) — a potentially life-threatening lung blockage and the third most common cause of death ...
Healthcare professionals create care plans to help manage conditions such as pulmonary embolism. Planning may help improve outcomes and prevent future occurrences of the condition. Care plans are an ...
A new study using Boston Scientific's EkoSonic endovascular system (EKOS) aims to address current gaps in clinical guidelines for the treatment of pulmonary embolism. The first-of-its-kind trial will ...
The past couple of days have seen a handful of artificial intelligence algorithms for radiology imaging analysis receive 510(k) clearances from the FDA. Two of these, from Quantib and Ezra, are ...
Catheter-directed thrombolysis (CDT) is associated with a lower risk for death and major bleeding complications than systemic thrombolysis for patients with intermediate- or high-risk pulmonary ...
The right treatment for a pulmonary embolism depends on the size of the blood clot, complications you might be experiencing, and your risk of future blood clots. Options may include medications or ...
What Is a Pulmonary Embolism? A pulmonary embolism (PE) happens when a blood clot suddenly blocks an artery that supplies blood to your lungs. Pulmonary embolism happens when a blood clot travels ...
Angiodynamics, Inc. ((ANGO)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...
RapidAI, a health tech company that specializes in stroke imaging analysis, announced Tuesday it had received FDA 510(k) clearance for its product that aims to identify potential cases of central ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results